Podcast


Presenter: Dr. James McCormack Dr. Mike Allan Dr. Nicholas Dugré

In episode 579, Mike and James invite Nicholas Dugré back to the podcast to talk about the evidence around the benefits and harms of a new class of medications for the acute treatment of episodic migraines. Ubrogepant is an oral calcitonin gene-related peptide antagonist. In this case, amazing as it may sound, there are triple…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

In the Clinic Episode #32: Pediatric Asthma

In this episode of In the Clinic, Mike and Jess invite back Dr. Jennifer Young. The team discusses Brea Salter, a 4-year old girl presenting with wheezing. To earn an additional 0.25…
Listen 0.5 credits available

BS Medicine Episode #592: Pharm for Fibro: Can antidepressants ease the pain?

In episode 592, Mike and James invite Jennifer Young back to the podcast to review the evidence around the use of antidepressants in the challenging pain condition of fibromyalgia. We…
Listen 0.5 credits available

BS Medicine Episode #591: Testosterone supplementation for cis-gender men

In episode 591, Mike and James invite Samantha Moe back to the podcast to review the evidence for using testosterone in older men. We talk about the impact testosterone supplementation…
Listen 0.5 credits available

Presenter(s):

Dr. James McCormack Dr. Mike Allan Dr. Nicholas Dugré

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Dr. James McCormack
  • Dr. Mike Allan
  • Dr. Nicholas Dugré

Spearkers do not have any conflicts of interest to declare.